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ABSTRACT 
 
Infiltration of the arterial vessel wall with monocytes is one of the initial inflammatory events. 
Monocyte chemoattractant protein-1 (MCP-1) is the key chemokine for the recruitment of 
monocytes to the atherosclerotic lesion. So far, it is unknown, if strenuous exercise enhances 
or reduces the release of MCP-1, the key initiator of pro-atherosclerotic inflammatory events 
in patients at risk for atherosclerotic diseases. 15 Patients with at least three coronary risk 
factors (CRF) like smoking, hypertension, diabetes, hypercholesterolemia and overweight and 
17 corresponding healthy controls were tested with bicycle ergometry. Additionally, 8 
patients with coronary artery disease (CAD) were investigated. Before and 10 minutes after 
maximal exercise, venous blood was taken and MCP-1 serum levels were analyzed. 
Furthermore, we measured monocyte CD11b expression by flow cytometry. Independently of 
CRF, the MCP-1 serum level was significantly increased after exercise. In control subjects the 
MCP-1 serum level rose from 71 pg/ml to 94 pg/ml (p≤0.05). In patients with CRF the MCP-
1 serum level went up from 154 pg/ml to 224 pg/ml (p≤0.05). Patients with coronary artery 
disease had elevated MCP-1 serum levels before and after exercise, too, even if they did not 
have CRF (143 vs. 174 pg/ml; p≤0.05). The monocyte activation parameter CD11b showed a 
significant raise after physical exercise (relative fluorescence intensity 31 vs. 44; p≤0.05). 
These data indicate, that MCP-1 serum levels are elevated after physical exercise especially in 
patients at risk for coronary artery disease. These effects may in part result from an increased 
monocyte activation following strenuous physical exercise. 
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INTRODUCTION 
 
Monocyte chemoattractant protein-1 (MCP-
1) is a potent specific chemoattractant for 
monocytes without chemoattractant activity 
on neutrophils (Rollins 1997 for review). 
MCP-1 is shown to be secreted by cytokine-
activated endothelial cells and vascular 
smooth muscle cells (Rollins et al. 1991; 
Poon et al. 1996) in vitro. There is evidence, 
that not only cytokine-activation but also 
interaction of activated platelets with 
endothelial cells or monocytes can induce 
MCP-1 secretion. (Weyrich et al. 1995). 
 
Monocytes migrate into the intima due to a 
MCP-1 concentration gradient that is formed 
by endothelial and monocyte activation. 
Once inside the intima, the monocyte 
amplifies its signal by synthesizing and 
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secreting its own MCP-1 (Rollins et al. 
1995). MCP-1 was detected in macrophage-
rich areas of rabbit and human 
atherosclerotic plaques (Ylä-Herttuala et al. 
1991). A MCP-1 antibody inhibited 
transmigration of monocytes into the 
subspatial space. The ability of minimally 
modified LDL to activate MCP-1 production 
and secretion in cultured endothelial cells in 
vitro (Cushing et al. 1990) and in a rabbit 
model in vivo (Ylä-Herttuala et al. 1991) 
emphasizes its important role in 
atherogenesis. 
 
Several publications already investigated the 
effect of short term physical exercise on 
different cytokines and leukocyte surface 
molecules (Kühlwein et al. 2001; Hu et al. 
2004; Rhind et al. 2001; Meksawan et al. 
2004), but none of these investigated MCP-1 
as the chemokine that links monocyte 
activation directly  to vascular inflammation 
in patients with atherosclerotic vessel 
disease. 
 
METHODS 
 
Blood was drawn from the antecubital vein 
from 15 patients with CRF, from 8 patients 
with angiographically proven coronary artery 
disease and from 17 healthy age-matched 
volunteers (co) [mean age (years): CAD: 
64,8 ±5,7; co: 59 ± 4,7;  ±SEM, n.s.] before 
and after a maximal physical exercise testing 
by bicycle ergometry. In the patient group, 
the exercise test was terminated at the onset 
of angina or ST-segment depression. 
Cardiovascular risk factors like hypertension, 
hypercholesterolemia, diabetes mellitus, 
positive family history and nicotine abuse 
were evaluated in all patients and control 
subjects. For the diagnosis of obesity, the 
body-mass-index was calculated. Patients 
with a body mass index exceeding 25 were 
defined as obese. The medical history of each 
participant was evaluated. Routine blood 
tests were performed for creatinine, liver 
parameters, c-reactive protein, low-density 
lipoprotein cholesterol, hemoglobin 1C, and 
lipoprotein (a). Participants with elevated 
levels of creatinine, liver parameters and 
infectious parameters were excluded from the 
study. Serum levels of MCP-1 were 
measured with a commercially available 
ELISA-system (R&D Systems, Wiesbaden, 
Germany). In 4 patients, serum MCP-1 was 
determined 4 times the day at 8 am, noon, 4 
p.m. and 8 p.m. to test, if MCP-1 expression 
is stable throughout the day. 
 
The expression of the adhesion molecule L-
selectin  (CD62L) and CD11b were 
measured by a flow cytometer (FACScan, 
Becton-Dickinson, San Jose, CA, USA) by 
indirect immunofluorescence using 
corresponding murine monoclonal antibodies 
against L-selectin (Biodesign), CD11b and a 
FITC-labelled goat anti-mouse IgG antibody 
(Serotec, Immunotech). Mean fluorescence 
intensity was taken from the cells gated in 
the monocyte window. The non-specific 
binding was measured with the isotype 
control Ox 6, an IgG antibody against rat 
MHC class II-Antigen (a kind gift of Dr. J. 
Reske, Institute of Immunology, Mainz, 
FRG), which is not expressed on monocytes. 
Non-specific binding was <1% throughout 
all experiments. The labeling was performed 
as follows: 42 or 40µl blood was incubated 
with 8 or 10 µl of the CD11b or CD62L 
antibody, respectively,  at 4°C for 45 
minutes. 2 ml of FACS-Lysis solution 
(Becton-Dickenson) were added and 
incubated another 20 minutes at 4°C. The 
samples were centrifuged at 240 x g for 5 
minutes and the pellet was fixed in 0.5% 
paraformaldehyde over 10 minutes at 4°C. 
The samples were centrifuged again and 
resuspended in FACS-buffer (Becton 
Dickenson) with 0.1% sodium azide. 
 
Data are given as mean ± SEM. Student’s t-
test for unpaired data or ANOVA was 
applied where appropriate. A p-value below 
0.05 was considered significant. 
 
RESULTS AND DISCUSSION 
 
Monocyte chemoattractant protein-1 (MCP-
1) is a secreted chemokine that exhibits 
powerful monocyte chemoattractant 
properties even at an extremely low 
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picomolar concentration range. MCP-1 
mRNA and protein was detected in rabbit 
and human atherosclerotic lesions (Ylä-
Herttuala et al. 1991; Nelken et al. 1991). So 
far, the role of circulating MCP-1 and its 
relationship to human atherosclerotic 
diseases is not well-defined. So far, there do 
not exist many data about the MCP-1 serum 
level in a healthy population. However, some 
studies investigated patients with 
cardiovascular diseases, but the data are not 
consistent so far. One study demonstrated 
that circulating levels of MCP-1 and tissue 
factor are simultaneously increased in 
patients with acute coronary syndromes. 
Patients with stable exertional angina did not 
show increased MCP-1 serum levels 
(Nishiyama et al. 1998). Aging as a risk 
factor for atherosclerotic diseases was 
already investigated before (Inadera et al. 
1999). The authors already stated, that this 
increase in MCP-1 serum levels with age 
might reflect the existence of atherosclerosis. 
However, they did not find increased MCP-1 
levels in patients with stroke or coronary 
artery disease. One possible explanation is, 
that the authors did not differentiate healthy 
subjects from subjects with multiple coronary 
risk factors. 
 
 
 
Although not subject to this study, our data 
imply elevated MCP-1 serum levels in 
patients with atherosclerotic diseases or 
multiple risk factors, but this issue was 
investigated in detail in a further study of our 
group (Lindemann et al., manuscript 
submitted 2004). In healthy control patients 
we found a MCP-1 Serum level of 71pg/ml. 
In patients with CRF the MCP-serum level 
was 154pg/ml at baseline. After physical 
exercise the MCP-1 level increased to 
94pg/ml in the healthy controls compared to 
224pg/ml in the CRF-patients group (Figure 
1). There are several reasons why the MCP-1 
levels rise after exercise: Physical exercise 
increases shear stress. Shear stress activates 
endothelium and monocytes, both of which 
may release MCP-1. In both groups, the 
healthy controls and the patients with CRF, 
the MCP-1 serum level increase after 
physical exercise, but the increase in the 
patients group is much more pronounced. In 
patients with atherosclerotic diseases, the 
elasticity of the vessels is reduced. This may 
increase the shear stress and enhance 
endothelial and monocyte activation. Patients 
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with angiographically proven CAD had a 
MCP-1 baseline level of 143pg/ml. After 
physical exercise, the MCP-1 level raised to 
174pg/ml. (Figure 2). We do not know the 
exact reason, why the patients with a 
manifest CAD do not increase to the same 
MCP-1 levels after exercise like the patients 
with CRF do. 
 
 
 
One explanation is that patients with CAD 
receive ß-blockers that limit maximal heart 
rate during exercise. These patients also 
receive aspirin that reduces platelet-
monocyte interaction. in an earlier 
publication, we even showed, that patients 
with CAD had a reduced platelet activity 
after exercise, most likely due to an increased 
inhibitory mediator release (Lindemann et al. 
1999). There are a few studies that 
investigated the effects of strenuous exercise 
on leukocyte and platelet activation and on 
inflammatory mediators. Consistent with our 
data is a Japanese paper that states a systemic 
inflammatory response to short term exercise 
in a healthy population. Besides other 
cytokines, MCP-1 serum levels augment 
after strenuous exercise (Suzuki et al. 2002). 
Hu et al. (2004) found platelet and monocyte 
hyperactivity in diabetic patients at baseline, 
but no substantial change after exercise in 
well –controlled diabetic patients compared 
to healthy controls. Poorly-controlled 
diabetic patients were not studied. Their data 
are conflict with ours, but our patient 
population was the typical CAD population. 
Our patients were much older and had 
probably more vascular complications.  
However, they found also an increase in 
CD11b adhesion molecule expression. 
Monocyte CD11b was significantly increased 
in our patients, regardless of CRF or CAD 
(Figure 3). CD62L on the monocyte did not 
change significantly. One reason might be an 
increased CD62L shedding from the 
monocyte surface after maximal exercise due 
to enhanced shear stress exposure of the 
monocytes. However, an American study 
found an increased CD62L expression in 
adolescent girls after water polo practice 
(Nemet et al. 2003), but the study population 
is significantly different from ours. In two 
German studies, young healthy non-smokers 
were investigated for platelet-leukocyte 
aggregates after maximal exercise, and both 
studies were able to show increased platelet-
leukocyte formation after exercise (Hilberg et 
al. 2003, Hilberg et al. 2004). Taken together 
these data show an increased monocyte 
activation even in healthy controls. 
 
In conclusion, physical exercise induces an 
inflammatory response that is expressed by 
an increased MCP-1 serum level after 
exercise. This is in part due to an enhanced 
monocyte activation. Also, endothelial 
activation might contribute to this 
inflammatory response, but endothelial 
activation parameters were not investigated 
in this study. In patients with CAD this 
inflammatory response is enhanced 
compared to healthy controls, most likely due 
to an increased baseline inflammatory burden 
of the patients with endothelial dysfunction 
and atherosclerotic vessel diseases. 
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